A solutions portfolio available for all the main key modalities, including: X-ray Imaging (conventional X-ray and Computed Tomography), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound and Nuclear Medicine through radioactive tracers. The portfolio offering has been broadened with the acquisition of E-Z-EM, Inc in 2008, a major manufacturer of contrast media and medical devices for gastrointestinal (GI) applications, and Swiss Medical Care in 2011, now Bracco Injeenering, whic